Ireland - English - HPRA (Health Products Regulatory Authority)

novartis ireland limited - ciclosporin - concentrate for solution for infusion - 50 milligram(s)/millilitre - calcineurin inhibitors; ciclosporin

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - ciclosporin - solution for infusion - 50mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - ciclosporin - solution for infusion - 50mg/1ml

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - ciclosporin 50 mg/ml - solution for infusion - 250 mg/5ml - active: ciclosporin 50 mg/ml excipient: ethanol polyoxyl 35 castor oil - solid organ transplantation prevention of graft rejection following kidney, liver, heart, combined heart-lung, lung or pancreas allogeneic transplantations. treatment of transplant rejection in patients previously receiving other immunosuppressive agents. bone marrow transplantation prevention of graft rejection following bone marrow transplantation. prevention or treatment of graft-versus-host disease (gvhd).

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - ciclosporin - concentrate for soln for inf - 50 mg/ml - calcineurin inhibitors

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

novartis pharma ag, switzerland - ciclosporin - concentrate for solution for infusion - 50 mg/ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

novartis - ciclosporin - concentrate for solution for infusion - 50 mg/ml

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - ciclosporin - concentrate for solution for infusion - ciclosporin 50 mg/ml - immunosuppressants

Israel - English - Ministry of Health

novartis israel ltd - ciclosporin - solution for infusion - ciclosporin 50 mg/ml - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

novartis pharma ag, switzerland - ciclosporin - concentrate for solution for infusion - 50 mg/ml